Trade Rep Hints At More CFIUS Scrutiny Of Biotech Deals
Foreign acquisitions and investments in the U.S. biotechnology industry have been highlighted by the Trump administration in the voluminous Section 301 report issued March 22, 2018, by the United States Trade...To view the full article, register now.
Already a subscriber? Click here to view full article